Your browser doesn't support javascript.
loading
Ribosome inactivation by Escherichia coli GTPase RsgA inhibits T4 phage.
Fernández-García, Laura; Tomás, María; Wood, Thomas K.
Affiliation
  • Fernández-García L; Department of Chemical Engineering, Pennsylvania State University, University Park, PA, United States.
  • Tomás M; Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC) and Microbiology Department of Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
  • Wood TK; Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC) and Microbiology Department of Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain.
Front Microbiol ; 14: 1242163, 2023.
Article in En | MEDLINE | ID: mdl-37670987
ABSTRACT

Introduction:

Bacteria must combat phages, and myriad bacterial anti-phage systems have been discovered that reduce host metabolism, for example, by depleting energetic compounds like ATP and NAD+. Hence, these systems indirectly inhibit protein production. Surprisingly, direct reduction of ribosome activity has not been demonstrated to thwart phage.

Methods:

Here, by producing each of the 4,287 Escherichia coli proteins and selecting for anti-phage activity that leads to enhanced growth, we investigated the role of host proteins in phage inhibition. Results and

discussion:

We identified that E. coli GTPase RsgA inhibits lytic phage T4 by inactivating ribosomes.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Microbiol Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Microbiol Year: 2023 Document type: Article Affiliation country: United States